CONCLUSION
EMH is a well-established complication of thalassemia major and can
manifest in variable forms ranging from asymptomatic hepatosplenomegaly
to skeletal malformations causing serious adverse effects such as SCC
which is rarely encountered but should always be held in mind when
assessing patients with TDBT.